Use and cost comparison of clobazam to other antiepileptic drugs for treatment of Lennox-Gastaut syndrome

Background: Lennox-Gastaut syndrome (LGS) is a severe form of childhood-onset epilepsy associated with serious injuries due to frequent and severe seizures. Of the antiepileptic drugs (AEDs) approved for LGS, clobazam is a more recent market entrant, having been approved in October 2011. Recent AED...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Mark Access Health Policy
Autori principali: François, Clément, Stern, John M., Ogbonnaya, Augustina, Lokhandwala, Tasneem, Landsman-Blumberg, Pamela, Duhig, Amy, Shen, Vivienne, Tan, Robin
Natura: Artigo
Lingua:Inglês
Pubblicazione: Routledge 2017
Soggetti:
Transferred Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5508372/
https://ncbi.nlm.nih.gov/pubmed/28740620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20016689.2017.1318691
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi